MiR-495	B:C1826049
functions	O
as	O
an	O
adjuvant	O
to	O
radiation	O
therapy	I:C1522449
by	O
reducing	O
the	O
radiation	O
-	I:C0949629
induced	I:C0949629
bystander	I:C0949629
effect	I:C0949629
.	O

MiR-495	O
functions	B:C0314627
as	O
an	O
adjuvant	O
to	O
radiation	O
therapy	I:C1522449
by	O
reducing	O
the	O
radiation	O
-	I:C0949629
induced	I:C0949629
bystander	I:C0949629
effect	I:C0949629
.	O

MiR-495	O
functions	O
as	O
an	O
adjuvant	O
to	O
radiation	B:C1522449
therapy	I:C1522449
by	O
reducing	O
the	O
radiation	O
-	I:C0949629
induced	I:C0949629
bystander	I:C0949629
effect	I:C0949629
.	O

MiR-495	O
functions	O
as	O
an	O
adjuvant	O
to	O
radiation	O
therapy	I:C1522449
by	O
reducing	O
the	O
radiation	B:C0949629
-	I:C0949629
induced	I:C0949629
bystander	I:C0949629
effect	I:C0949629
.	O

The	O
radiation	B:C0949629
-	I:C0949629
induced	I:C0949629
bystander	I:C0949629
effect	I:C0949629
(	O
radiation	O
-	I:C0949629
induced	I:C0949629
bystander	I:C0949629
effect	I:C0949629
)	O
is	O
an	O
important	O
factor	O
in	O
tumor	O
radiation	O
therapy	I:C1522449
because	O
it	O
may	O
increase	O
the	O
probability	O
of	O
normal	O
cellular	O
injury	O
and	O
the	O
likelihood	O
of	O
secondary	O
cancers	I:C0027627
after	O
radiotherapy	O
.	O

The	O
radiation	O
-	I:C0949629
induced	I:C0949629
bystander	I:C0949629
effect	I:C0949629
(	O
radiation	B:C0949629
-	I:C0949629
induced	I:C0949629
bystander	I:C0949629
effect	I:C0949629
)	O
is	O
an	O
important	O
factor	O
in	O
tumor	O
radiation	O
therapy	I:C1522449
because	O
it	O
may	O
increase	O
the	O
probability	O
of	O
normal	O
cellular	O
injury	O
and	O
the	O
likelihood	O
of	O
secondary	O
cancers	I:C0027627
after	O
radiotherapy	O
.	O

The	O
radiation	O
-	I:C0949629
induced	I:C0949629
bystander	I:C0949629
effect	I:C0949629
(	O
radiation	O
-	I:C0949629
induced	I:C0949629
bystander	I:C0949629
effect	I:C0949629
)	O
is	O
an	O
important	O
factor	O
in	O
tumor	B:C0027651
radiation	O
therapy	I:C1522449
because	O
it	O
may	O
increase	O
the	O
probability	O
of	O
normal	O
cellular	O
injury	O
and	O
the	O
likelihood	O
of	O
secondary	O
cancers	I:C0027627
after	O
radiotherapy	O
.	O

The	O
radiation	O
-	I:C0949629
induced	I:C0949629
bystander	I:C0949629
effect	I:C0949629
(	O
radiation	O
-	I:C0949629
induced	I:C0949629
bystander	I:C0949629
effect	I:C0949629
)	O
is	O
an	O
important	O
factor	O
in	O
tumor	O
radiation	B:C1522449
therapy	I:C1522449
because	O
it	O
may	O
increase	O
the	O
probability	O
of	O
normal	O
cellular	O
injury	O
and	O
the	O
likelihood	O
of	O
secondary	O
cancers	I:C0027627
after	O
radiotherapy	O
.	O

The	O
radiation	O
-	I:C0949629
induced	I:C0949629
bystander	I:C0949629
effect	I:C0949629
(	O
radiation	O
-	I:C0949629
induced	I:C0949629
bystander	I:C0949629
effect	I:C0949629
)	O
is	O
an	O
important	O
factor	O
in	O
tumor	O
radiation	O
therapy	I:C1522449
because	O
it	O
may	O
increase	O
the	O
probability	O
of	O
normal	O
cellular	O
injury	O
and	O
the	O
likelihood	O
of	O
secondary	B:C0027627
cancers	I:C0027627
after	O
radiotherapy	O
.	O

The	O
radiation	O
-	I:C0949629
induced	I:C0949629
bystander	I:C0949629
effect	I:C0949629
(	O
radiation	O
-	I:C0949629
induced	I:C0949629
bystander	I:C0949629
effect	I:C0949629
)	O
is	O
an	O
important	O
factor	O
in	O
tumor	O
radiation	O
therapy	I:C1522449
because	O
it	O
may	O
increase	O
the	O
probability	O
of	O
normal	O
cellular	O
injury	O
and	O
the	O
likelihood	O
of	O
secondary	O
cancers	I:C0027627
after	O
radiotherapy	B:C1522449
.	O

Here	O
,	O
we	O
identified	O
the	O
role	O
of	O
miR-495	B:C1826049
in	O
alleviating	O
RIBEs	O
during	O
radiotherapy	O
.	O

Here	O
,	O
we	O
identified	O
the	O
role	O
of	O
miR-495	O
in	O
alleviating	O
RIBEs	B:C0949629
during	O
radiotherapy	O
.	O

Here	O
,	O
we	O
identified	O
the	O
role	O
of	O
miR-495	O
in	O
alleviating	O
RIBEs	O
during	O
radiotherapy	B:C1522449
.	O

Luciferase	B:C0005507
reporter	I:C0005507
assay	I:C0005507
results	O
confirmed	O
that	O
miR-495	O
regulated	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
(	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
)	O
by	O
targeting	O
the	O
Sp1	O
3	O
'-	I:C0600600
untranslated	I:C0600600
region	I:C0600600
.	O

Luciferase	O
reporter	I:C0005507
assay	I:C0005507
results	O
confirmed	B:C0750484
that	O
miR-495	O
regulated	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
(	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
)	O
by	O
targeting	O
the	O
Sp1	O
3	O
'-	I:C0600600
untranslated	I:C0600600
region	I:C0600600
.	O

Luciferase	O
reporter	I:C0005507
assay	I:C0005507
results	O
confirmed	O
that	O
miR-495	B:C1826049
regulated	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
(	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
)	O
by	O
targeting	O
the	O
Sp1	O
3	O
'-	I:C0600600
untranslated	I:C0600600
region	I:C0600600
.	O

Luciferase	O
reporter	I:C0005507
assay	I:C0005507
results	O
confirmed	O
that	O
miR-495	O
regulated	O
endothelial	B:C0669365
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
(	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
)	O
by	O
targeting	O
the	O
Sp1	O
3	O
'-	I:C0600600
untranslated	I:C0600600
region	I:C0600600
.	O

Luciferase	O
reporter	I:C0005507
assay	I:C0005507
results	O
confirmed	O
that	O
miR-495	O
regulated	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
(	O
endothelial	B:C0669365
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
)	O
by	O
targeting	O
the	O
Sp1	O
3	O
'-	I:C0600600
untranslated	I:C0600600
region	I:C0600600
.	O

Luciferase	O
reporter	I:C0005507
assay	I:C0005507
results	O
confirmed	O
that	O
miR-495	O
regulated	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
(	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
)	O
by	O
targeting	O
the	O
Sp1	B:C0080245
3	O
'-	I:C0600600
untranslated	I:C0600600
region	I:C0600600
.	O

Luciferase	O
reporter	I:C0005507
assay	I:C0005507
results	O
confirmed	O
that	O
miR-495	O
regulated	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
(	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
)	O
by	O
targeting	O
the	O
Sp1	O
3	B:C0600600
'-	I:C0600600
untranslated	I:C0600600
region	I:C0600600
.	O

Consequently	O
,	O
after	O
radiation	O
,	O
tumor	B:C0597032
cells	I:C0597032
expressed	O
less	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
and	O
Sp1	O
than	O
controls	O
.	O

Consequently	O
,	O
after	O
radiation	O
,	O
tumor	O
cells	I:C0597032
expressed	B:C1171362
less	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
and	O
Sp1	O
than	O
controls	O
.	O

Consequently	O
,	O
after	O
radiation	O
,	O
tumor	O
cells	I:C0597032
expressed	O
less	O
endothelial	B:C0669365
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
and	O
Sp1	O
than	O
controls	O
.	O

Consequently	O
,	O
after	O
radiation	O
,	O
tumor	O
cells	I:C0597032
expressed	O
less	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
and	O
Sp1	B:C0080245
than	O
controls	O
.	O

In	O
vitro	O
cell	O
irradiation	O
data	O
based	O
on	O
flow	B:C0936012
-	I:C0936012
cytometric	I:C0936012
analysis	I:C0936012
and	O
enzymed	O
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
confirmed	O
that	O
nitric	O
oxide	I:C0028128
(	O
nitric	O
oxide	I:C0028128
)	O
and	O
its	O
downstream	O
product	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
(	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
)	O
were	O
critical	O
signaling	O
factors	O
contributing	O
to	O
RIBEs	O
.	O

In	O
vitro	O
cell	O
irradiation	O
data	O
based	O
on	O
flow	O
-	I:C0936012
cytometric	I:C0936012
analysis	I:C0936012
and	O
enzymed	B:C0014441
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
confirmed	O
that	O
nitric	O
oxide	I:C0028128
(	O
nitric	O
oxide	I:C0028128
)	O
and	O
its	O
downstream	O
product	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
(	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
)	O
were	O
critical	O
signaling	O
factors	O
contributing	O
to	O
RIBEs	O
.	O

In	O
vitro	O
cell	O
irradiation	O
data	O
based	O
on	O
flow	O
-	I:C0936012
cytometric	I:C0936012
analysis	I:C0936012
and	O
enzymed	O
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
confirmed	B:C0750484
that	O
nitric	O
oxide	I:C0028128
(	O
nitric	O
oxide	I:C0028128
)	O
and	O
its	O
downstream	O
product	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
(	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
)	O
were	O
critical	O
signaling	O
factors	O
contributing	O
to	O
RIBEs	O
.	O

In	O
vitro	O
cell	O
irradiation	O
data	O
based	O
on	O
flow	O
-	I:C0936012
cytometric	I:C0936012
analysis	I:C0936012
and	O
enzymed	O
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
confirmed	O
that	O
nitric	B:C0028128
oxide	I:C0028128
(	O
nitric	O
oxide	I:C0028128
)	O
and	O
its	O
downstream	O
product	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
(	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
)	O
were	O
critical	O
signaling	O
factors	O
contributing	O
to	O
RIBEs	O
.	O

In	O
vitro	O
cell	O
irradiation	O
data	O
based	O
on	O
flow	O
-	I:C0936012
cytometric	I:C0936012
analysis	I:C0936012
and	O
enzymed	O
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
confirmed	O
that	O
nitric	O
oxide	I:C0028128
(	O
nitric	B:C0028128
oxide	I:C0028128
)	O
and	O
its	O
downstream	O
product	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
(	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
)	O
were	O
critical	O
signaling	O
factors	O
contributing	O
to	O
RIBEs	O
.	O

In	O
vitro	O
cell	O
irradiation	O
data	O
based	O
on	O
flow	O
-	I:C0936012
cytometric	I:C0936012
analysis	I:C0936012
and	O
enzymed	O
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
confirmed	O
that	O
nitric	O
oxide	I:C0028128
(	O
nitric	O
oxide	I:C0028128
)	O
and	O
its	O
downstream	B:C0522506
product	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
(	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
)	O
were	O
critical	O
signaling	O
factors	O
contributing	O
to	O
RIBEs	O
.	O

In	O
vitro	O
cell	O
irradiation	O
data	O
based	O
on	O
flow	O
-	I:C0936012
cytometric	I:C0936012
analysis	I:C0936012
and	O
enzymed	O
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
confirmed	O
that	O
nitric	O
oxide	I:C0028128
(	O
nitric	O
oxide	I:C0028128
)	O
and	O
its	O
downstream	O
product	O
transforming	B:C1704256
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
(	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
)	O
were	O
critical	O
signaling	O
factors	O
contributing	O
to	O
RIBEs	O
.	O

In	O
vitro	O
cell	O
irradiation	O
data	O
based	O
on	O
flow	O
-	I:C0936012
cytometric	I:C0936012
analysis	I:C0936012
and	O
enzymed	O
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
confirmed	O
that	O
nitric	O
oxide	I:C0028128
(	O
nitric	O
oxide	I:C0028128
)	O
and	O
its	O
downstream	O
product	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
(	O
transforming	B:C1704256
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
)	O
were	O
critical	O
signaling	O
factors	O
contributing	O
to	O
RIBEs	O
.	O

In	O
vitro	O
cell	O
irradiation	O
data	O
based	O
on	O
flow	O
-	I:C0936012
cytometric	I:C0936012
analysis	I:C0936012
and	O
enzymed	O
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
confirmed	O
that	O
nitric	O
oxide	I:C0028128
(	O
nitric	O
oxide	I:C0028128
)	O
and	O
its	O
downstream	O
product	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
(	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
)	O
were	O
critical	O
signaling	B:C3537152
factors	O
contributing	O
to	O
RIBEs	O
.	O

In	O
vitro	O
cell	O
irradiation	O
data	O
based	O
on	O
flow	O
-	I:C0936012
cytometric	I:C0936012
analysis	I:C0936012
and	O
enzymed	O
linked	I:C0014441
immunosorbent	I:C0014441
assay	I:C0014441
confirmed	O
that	O
nitric	O
oxide	I:C0028128
(	O
nitric	O
oxide	I:C0028128
)	O
and	O
its	O
downstream	O
product	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
(	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
)	O
were	O
critical	O
signaling	O
factors	O
contributing	O
to	O
RIBEs	B:C0949629
.	O

Fewer	O
normal	O
LO2	B:C0227525
liver	I:C0227525
cells	I:C0227525
were	O
injured	O
and	O
fewer	O
micronuclei	O
were	O
observed	O
when	O
treated	O
with	O
the	O
medium	O
of	O
the	O
miR-495	O
overexpressing	O
HepG2	O
and	O
ZR75	O
-	I:C0007634
1	I:C0007634
tumor	O
cells	I:C0597032
.	O

Fewer	O
normal	O
LO2	O
liver	I:C0227525
cells	I:C0227525
were	O
injured	O
and	O
fewer	O
micronuclei	B:C0026004
were	O
observed	O
when	O
treated	O
with	O
the	O
medium	O
of	O
the	O
miR-495	O
overexpressing	O
HepG2	O
and	O
ZR75	O
-	I:C0007634
1	I:C0007634
tumor	O
cells	I:C0597032
.	O

Fewer	O
normal	O
LO2	O
liver	I:C0227525
cells	I:C0227525
were	O
injured	O
and	O
fewer	O
micronuclei	O
were	O
observed	O
when	O
treated	O
with	O
the	O
medium	O
of	O
the	O
miR-495	B:C1826049
overexpressing	O
HepG2	O
and	O
ZR75	O
-	I:C0007634
1	I:C0007634
tumor	O
cells	I:C0597032
.	O

Fewer	O
normal	O
LO2	O
liver	I:C0227525
cells	I:C0227525
were	O
injured	O
and	O
fewer	O
micronuclei	O
were	O
observed	O
when	O
treated	O
with	O
the	O
medium	O
of	O
the	O
miR-495	O
overexpressing	B:C0017262
HepG2	O
and	O
ZR75	O
-	I:C0007634
1	I:C0007634
tumor	O
cells	I:C0597032
.	O

Fewer	O
normal	O
LO2	O
liver	I:C0227525
cells	I:C0227525
were	O
injured	O
and	O
fewer	O
micronuclei	O
were	O
observed	O
when	O
treated	O
with	O
the	O
medium	O
of	O
the	O
miR-495	O
overexpressing	O
HepG2	B:C2717940
and	O
ZR75	O
-	I:C0007634
1	I:C0007634
tumor	O
cells	I:C0597032
.	O

Fewer	O
normal	O
LO2	O
liver	I:C0227525
cells	I:C0227525
were	O
injured	O
and	O
fewer	O
micronuclei	O
were	O
observed	O
when	O
treated	O
with	O
the	O
medium	O
of	O
the	O
miR-495	O
overexpressing	O
HepG2	O
and	O
ZR75	B:C0007634
-	I:C0007634
1	I:C0007634
tumor	O
cells	I:C0597032
.	O

Fewer	O
normal	O
LO2	O
liver	I:C0227525
cells	I:C0227525
were	O
injured	O
and	O
fewer	O
micronuclei	O
were	O
observed	O
when	O
treated	O
with	O
the	O
medium	O
of	O
the	O
miR-495	O
overexpressing	O
HepG2	O
and	O
ZR75	O
-	I:C0007634
1	I:C0007634
tumor	B:C0597032
cells	I:C0597032
.	O

Accordingly	O
,	O
treatment	B:C0087111
with	O
the	O
miR-495	O
antagomir	O
led	O
to	O
higher	O
nitric	O
oxide	I:C0028128
and	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
levels	O
and	O
more	O
injured	O
LO2	O
cells	I:C0227525
.	O

Accordingly	O
,	O
treatment	O
with	O
the	O
miR-495	B:C1826049
antagomir	O
led	O
to	O
higher	O
nitric	O
oxide	I:C0028128
and	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
levels	O
and	O
more	O
injured	O
LO2	O
cells	I:C0227525
.	O

Accordingly	O
,	O
treatment	O
with	O
the	O
miR-495	O
antagomir	B:C4277666
led	O
to	O
higher	O
nitric	O
oxide	I:C0028128
and	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
levels	O
and	O
more	O
injured	O
LO2	O
cells	I:C0227525
.	O

Accordingly	O
,	O
treatment	O
with	O
the	O
miR-495	O
antagomir	O
led	O
to	O
higher	O
nitric	B:C0028128
oxide	I:C0028128
and	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
levels	O
and	O
more	O
injured	O
LO2	O
cells	I:C0227525
.	O

Accordingly	O
,	O
treatment	O
with	O
the	O
miR-495	O
antagomir	O
led	O
to	O
higher	O
nitric	O
oxide	I:C0028128
and	O
transforming	B:C1704256
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
levels	O
and	O
more	O
injured	O
LO2	O
cells	I:C0227525
.	O

Accordingly	O
,	O
treatment	O
with	O
the	O
miR-495	O
antagomir	O
led	O
to	O
higher	O
nitric	O
oxide	I:C0028128
and	O
transforming	O
growth	I:C1704256
factor	I:C1704256
β	I:C1704256
1	I:C1704256
levels	O
and	O
more	O
injured	O
LO2	B:C0227525
cells	I:C0227525
.	O

In	B:C1515655
vivo	I:C1515655
experiments	O
indicated	O
that	O
local	O
irradiation	O
of	O
tumors	O
overexpressing	O
miR-495	O
produced	O
fewer	O
necrotic	O
foci	I:C0333504
in	O
non-irradiated	O
liver	I:C0736268
tissue	I:C0736268
compared	O
with	O
controls	O
.	O

In	O
vivo	I:C1515655
experiments	B:C0681814
indicated	O
that	O
local	O
irradiation	O
of	O
tumors	O
overexpressing	O
miR-495	O
produced	O
fewer	O
necrotic	O
foci	I:C0333504
in	O
non-irradiated	O
liver	I:C0736268
tissue	I:C0736268
compared	O
with	O
controls	O
.	O

In	O
vivo	I:C1515655
experiments	O
indicated	B:C1444656
that	O
local	O
irradiation	O
of	O
tumors	O
overexpressing	O
miR-495	O
produced	O
fewer	O
necrotic	O
foci	I:C0333504
in	O
non-irradiated	O
liver	I:C0736268
tissue	I:C0736268
compared	O
with	O
controls	O
.	O

In	O
vivo	I:C1515655
experiments	O
indicated	O
that	O
local	O
irradiation	O
of	O
tumors	B:C0027651
overexpressing	O
miR-495	O
produced	O
fewer	O
necrotic	O
foci	I:C0333504
in	O
non-irradiated	O
liver	I:C0736268
tissue	I:C0736268
compared	O
with	O
controls	O
.	O

In	O
vivo	I:C1515655
experiments	O
indicated	O
that	O
local	O
irradiation	O
of	O
tumors	O
overexpressing	B:C0017262
miR-495	O
produced	O
fewer	O
necrotic	O
foci	I:C0333504
in	O
non-irradiated	O
liver	I:C0736268
tissue	I:C0736268
compared	O
with	O
controls	O
.	O

In	O
vivo	I:C1515655
experiments	O
indicated	O
that	O
local	O
irradiation	O
of	O
tumors	O
overexpressing	O
miR-495	B:C1826049
produced	O
fewer	O
necrotic	O
foci	I:C0333504
in	O
non-irradiated	O
liver	I:C0736268
tissue	I:C0736268
compared	O
with	O
controls	O
.	O

In	O
vivo	I:C1515655
experiments	O
indicated	O
that	O
local	O
irradiation	O
of	O
tumors	O
overexpressing	O
miR-495	O
produced	O
fewer	O
necrotic	B:C0333504
foci	I:C0333504
in	O
non-irradiated	O
liver	I:C0736268
tissue	I:C0736268
compared	O
with	O
controls	O
.	O

In	O
vivo	I:C1515655
experiments	O
indicated	O
that	O
local	O
irradiation	O
of	O
tumors	O
overexpressing	O
miR-495	O
produced	O
fewer	O
necrotic	O
foci	I:C0333504
in	O
non-irradiated	B:C0736268
liver	I:C0736268
tissue	I:C0736268
compared	O
with	O
controls	O
.	O

miR-495	B:C1826049
was	O
upregulated	O
in	O
clinical	O
cancer	O
tissues	O
compared	O
with	O
adjacent	O
non-cancerous	O
tissues	I:C0040300
,	O
and	O
radiation	O
significantly	O
reduced	O
the	O
expression	O
level	O
of	O
miR-495	O
in	O
carcinoma	O
cell	I:C0596890
lines	I:C0596890
.	O

miR-495	O
was	O
upregulated	B:C0041904
in	O
clinical	O
cancer	O
tissues	O
compared	O
with	O
adjacent	O
non-cancerous	O
tissues	I:C0040300
,	O
and	O
radiation	O
significantly	O
reduced	O
the	O
expression	O
level	O
of	O
miR-495	O
in	O
carcinoma	O
cell	I:C0596890
lines	I:C0596890
.	O

miR-495	O
was	O
upregulated	O
in	O
clinical	O
cancer	B:C0006826
tissues	O
compared	O
with	O
adjacent	O
non-cancerous	O
tissues	I:C0040300
,	O
and	O
radiation	O
significantly	O
reduced	O
the	O
expression	O
level	O
of	O
miR-495	O
in	O
carcinoma	O
cell	I:C0596890
lines	I:C0596890
.	O

miR-495	O
was	O
upregulated	O
in	O
clinical	O
cancer	O
tissues	B:C0040300
compared	O
with	O
adjacent	O
non-cancerous	O
tissues	I:C0040300
,	O
and	O
radiation	O
significantly	O
reduced	O
the	O
expression	O
level	O
of	O
miR-495	O
in	O
carcinoma	O
cell	I:C0596890
lines	I:C0596890
.	O

miR-495	O
was	O
upregulated	O
in	O
clinical	O
cancer	O
tissues	O
compared	O
with	O
adjacent	B:C0205117
non-cancerous	O
tissues	I:C0040300
,	O
and	O
radiation	O
significantly	O
reduced	O
the	O
expression	O
level	O
of	O
miR-495	O
in	O
carcinoma	O
cell	I:C0596890
lines	I:C0596890
.	O

miR-495	O
was	O
upregulated	O
in	O
clinical	O
cancer	O
tissues	O
compared	O
with	O
adjacent	O
non-cancerous	B:C0040300
tissues	I:C0040300
,	O
and	O
radiation	O
significantly	O
reduced	O
the	O
expression	O
level	O
of	O
miR-495	O
in	O
carcinoma	O
cell	I:C0596890
lines	I:C0596890
.	O

miR-495	O
was	O
upregulated	O
in	O
clinical	O
cancer	O
tissues	O
compared	O
with	O
adjacent	O
non-cancerous	O
tissues	I:C0040300
,	O
and	O
radiation	O
significantly	O
reduced	O
the	O
expression	O
level	O
of	O
miR-495	B:C1826049
in	O
carcinoma	O
cell	I:C0596890
lines	I:C0596890
.	O

miR-495	O
was	O
upregulated	O
in	O
clinical	O
cancer	O
tissues	O
compared	O
with	O
adjacent	O
non-cancerous	O
tissues	I:C0040300
,	O
and	O
radiation	O
significantly	O
reduced	O
the	O
expression	O
level	O
of	O
miR-495	O
in	O
carcinoma	B:C0596890
cell	I:C0596890
lines	I:C0596890
.	O

In	O
summary	B:C1706244
,	O
miR-495	O
may	O
have	O
promise	O
as	O
an	O
adjuvant	O
for	O
tumor	O
radiation	O
therapy	I:C1522449
to	O
decrease	O
RIBEs	O
involving	O
the	O
Sp1	O
/	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
pathway	O
.	O

In	O
summary	O
,	O
miR-495	B:C1826049
may	O
have	O
promise	O
as	O
an	O
adjuvant	O
for	O
tumor	O
radiation	O
therapy	I:C1522449
to	O
decrease	O
RIBEs	O
involving	O
the	O
Sp1	O
/	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
pathway	O
.	O

In	O
summary	O
,	O
miR-495	O
may	O
have	O
promise	O
as	O
an	O
adjuvant	O
for	O
tumor	B:C0027651
radiation	O
therapy	I:C1522449
to	O
decrease	O
RIBEs	O
involving	O
the	O
Sp1	O
/	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
pathway	O
.	O

In	O
summary	O
,	O
miR-495	O
may	O
have	O
promise	O
as	O
an	O
adjuvant	O
for	O
tumor	O
radiation	B:C1522449
therapy	I:C1522449
to	O
decrease	O
RIBEs	O
involving	O
the	O
Sp1	O
/	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
pathway	O
.	O

In	O
summary	O
,	O
miR-495	O
may	O
have	O
promise	O
as	O
an	O
adjuvant	O
for	O
tumor	O
radiation	O
therapy	I:C1522449
to	O
decrease	O
RIBEs	B:C0949629
involving	O
the	O
Sp1	O
/	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
pathway	O
.	O

In	O
summary	O
,	O
miR-495	O
may	O
have	O
promise	O
as	O
an	O
adjuvant	O
for	O
tumor	O
radiation	O
therapy	I:C1522449
to	O
decrease	O
RIBEs	O
involving	O
the	O
Sp1	B:C0080245
/	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
pathway	O
.	O

In	O
summary	O
,	O
miR-495	O
may	O
have	O
promise	O
as	O
an	O
adjuvant	O
for	O
tumor	O
radiation	O
therapy	I:C1522449
to	O
decrease	O
RIBEs	O
involving	O
the	O
Sp1	O
/	O
endothelial	B:C0669365
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
pathway	O
.	O

In	O
summary	O
,	O
miR-495	O
may	O
have	O
promise	O
as	O
an	O
adjuvant	O
for	O
tumor	O
radiation	O
therapy	I:C1522449
to	O
decrease	O
RIBEs	O
involving	O
the	O
Sp1	O
/	O
endothelial	O
nitric	I:C0669365
oxide	I:C0669365
synthase	I:C0669365
pathway	B:C1704259
.	O

